| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-13 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-13 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-12 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-11 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.28 | 5e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |